FDA refuse to file letter

A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis

FDA refuse to file letter

Postby bee26 » Tue Aug 28, 2012 12:41 am

The FDA have sent Genzyme/Sanofi a refuse to file letter. They're not asking for more trials, just for more info at the moment, but it will put back approval in the US by another 6 months or so. The EMA in Europe have accepted the application.
User avatar
Posts: 9
Joined: Tue Jan 12, 2010 3:00 pm


Return to Campath (Lemtrada, Alemtuzumab)

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service